Development of tolerance to the metabolic actions of beta 2-adrenoceptor stimulating drugs
Fredholm, B.B.; Lunell, N.O.; Persson, B.; Wager, J.
Acta Obstetricia et Gynecologica Scandinavica. Supplement 108: 53-59
1982
ISSN/ISBN: 0300-8835 PMID: 6289598 Document Number: 187777
Document emailed within 1 workday
Related Documents
Randrup, A.; Mogilnicka, E. 1976: Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems Polish Journal of Pharmacology and Pharmacy 28(6): 551-556Keith, R.A.; Hwang, T.F.; Murthy, V.S.; Kau, S.T.; Salama, A.I.; Giles, R.E. 1989: ICi 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues Journal of Pharmacology and Experimental Therapeutics 248(1): 240-248
Krum, H.; Pillay, P. 1998: New drugs, old drugs. Beta-adrenoceptor blocking agents Medical Journal of Australia 168(5): 232-235
Schulte, K.L.; Meyer-Sabellek, W.; Thiede, H.M.; Röcker, L.; Gotzen, R. 1987: Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol International Journal of Clinical Pharmacology Therapy and Toxicology 25(10): 539-544
Kazanietz, M.G.; Enero, M.A. 1990: Desensitization of the beta-2 adrenoceptor-mediated vasodilation in rat aorta after prolonged treatment with the beta-2 adrenoceptor agonist clenbuterol Journal of Pharmacology and Experimental Therapeutics 252(2): 758-764
Canepa-Anson, R.; Dawson, J.R.; Frankl, W.S.; Kuan, P.; Sutton, G.C.; Reuben, S.; Poole-Wilson, P.A. 1982: Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias European Heart Journal 3 Suppl D: 129-134
Maccarrone, C.; Malta, E.; Raper, C. 1985: Comparison of the Arrhythmogenic Actions of (-)-Isoprenaline, Dobutamine and the selective beta 1-adrenoceptor agonist, (+/-)-(1-[3',4'-dihydroxyphenoxy] -2-hydroxy-[3",4"-dimethoxy phenethylamino]-propane)-oxalate (Ro 363) Arzneimittel-Forschung 35(3): 592-598
Lorimer, A.R.; Jones, J.V.; Clark, B.; Dunn, F.G.; Melville, D.; Lawrie, T.D. 1976: Indications for beta-adrenoceptor blocking drugs in hypertension Postgraduate Medical Journal 52(Suppl 4): 81-85
Andersen, G.S.; Hartling, O.J.; Hein, H.O.; Leth, A. 1985: Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions Danish Medical Bulletin 32(5): 280-283
Elonen, E. 1975: Effect of beta-adrenoceptor blocking drugs, physostigmine, and atropine on the toxicity of doxepin in mice Medical Biology 53(4): 231-237
Hellenbrecht, D.; Enenkel, J. 1984: Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat Arzneimittel-Forschung 34(9): 980-983
Khanna, N.; Ray, A.; Alkondon, M.; Sen, P. 1989: Effect of beta-adrenoceptor antagonists and some related drugs on maximal electroshock seizures in mice Indian Journal of Experimental Biology 27(2): 128-130
Ahmed, H.M. 1975: Effect of calcium chloride on some metabolic actions of certain antidiabetic drugs in normal and alloxanised rabbits Die Pharmazie 30(9): 598-602
Shanks, R.G. 1981: Review of a review. Partial agonist activity of beta-adrenoceptor blocking drugs European Heart Journal 2(3): 253-255
Ellison, T.; Okun, R.; Silverman, A.; Siegel, M. 1971: Metabolic fate of amphetamine in the cat during development of tolerance Archives Internationales de Pharmacodynamie et de Therapie 190(1): 135-149
Singh, B.N. 1973: Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias New Zealand Medical Journal 78(504): 482-486
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Wirtzfeld, A.; Klein, G.; Bibra, H.V.; Sauer, E. 1985: Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity? International Journal of Clinical Pharmacology Therapy and Toxicology 23(1): 20-27
Dahlöf, B.; Andrén, L.; Svensson, A.; Hansson, L. 1983: Antihypertensive mechanism of beta-adrenoceptor antagonism--the role of beta 2-blockade Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 1(2): 112-115
Winter, J.C. 1971: Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component Journal of Pharmacology and Experimental Therapeutics 178(3): 625-630